Pharmacological Analysis of NLRP3 Inflammasome Inhibitor Sodium [(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl][(1-methyl-1<i>H</i>-pyrazol-4-yl)({[(2<i>S</i>)-oxolan-2-yl]methyl})sulfamoyl]azanide in Cellular and Mouse Models of Inflammation Provides a Translational Framework
John R. Doedens, Christopher A. Gabel(University of North Carolina at Chapel Hill), Christine Diamond(University of North Carolina at Chapel Hill), Andy Billinton(Chelmsford and Essex Hospital), MyTrang Nguyen(University of North Carolina at Chapel Hill), Beverly H. Koller(University of North Carolina at Chapel Hill), Heather Wescott(University of North Carolina at Chapel Hill), Pamela J. Smolak(University of North Carolina at Chapel Hill), David Harrison(University of Notre Dame), Alan P. Watt(Chelmsford and Essex Hospital), Ken Schooley
Cited by 8
Related Papers
Role of gammaENaC subunit in lung liquid clearance and electrolyte balance in newborn mice. Insights into perinatal adaptation and pseudohypoaldosteronism.
|Journal of Clinical Investigation|1998|255
Impaired Host Defense in Mice Lacking ONZIN
|The Journal of Immunology|2007|92
Ubiquitin Ligase Substrate Identification through Quantitative Proteomics at Both the Protein and Peptide Levels
|Journal of Biological Chemistry|2011|85
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
|Journal of Medicinal Chemistry|2023|62
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing
|European Journal of Pharmacology|2014|54